Clearside Biomedical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	8.23	1.33	29.58	7.89	2.17	0.03	0.35	0.52	0	0
Revenue Growth (YoY)	519.89%	-95.51%	274.65%	263.28%	7143.33%	-91.30%	-33.65%	-	-	-
Cost of Revenue	0.36	0.2	0	0	0	0	0	0	0	0
Gross Profit	7.87	1.12	29.58	7.89	2.17	0.03	0.35	0.52	0	0
Selling, General & Admin	11.87	11.77	11.67	10.76	16.82	14.68	9.7	6.26	6.56	3.13
Research & Development	20.85	19.63	18.54	15.07	15.66	68.29	49.05	19.46	10.76	6.69
Other Operating Expenses	0	0	0	0.28	0.47	0	0	0	0.32	0.37
Operating Expenses	32.72	31.4	30.2	26.1	32.94	82.98	58.75	25.72	17.64	10.19
Operating Income	-24.84	-30.28	-0.63	-18.21	-30.77	-82.95	-58.41	-25.2	-17.64	-10.19
Other Expense / Income	7.64	2.67	-1	-	-	-0.13	0.57	0.68	-	-
Pretax Income	-32.49	-32.95	0.38	-18.21	-30.77	-82.82	-58.98	-25.88	-17.64	-10.19
Net Income	-32.49	-32.95	0.38	-18.21	-30.77	-82.82	-58.98	-25.88	-17.64	-10.19
Shares Outstanding (Basic)	62	60	58	47	38	31	25	13	2	2
Shares Outstanding (Diluted)	62	60	60	47	38	31	25	13	2	2
Shares Change	2.66%	0.50%	28.81%	21.84%	24.20%	21.42%	93.06%	460.55%	34.53%	-
EPS (Basic)	-0.53	-0.55	0.01	-0.39	-0.81	-2.69	-2.33	-1.97	-7.54	-5.86
EPS (Diluted)	-0.53	-0.55	0.01	-0.39	-0.81	-2.69	-2.33	-1.97	-7.54	-5.86
Free Cash Flow	-19.91	-13.61	-10.73	-13.18	-27.09	-79.29	-51.39	-22.71	-13.93	-9.26
Free Cash Flow Per Share	-0.32	-0.23	-0.18	-0.28	-0.71	-2.58	-2.03	-1.73	-5.96	-5.33
Gross Margin	95.68%	84.63%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	-	-
Operating Margin	-302.02%	-2281.61%	-2.12%	-230.68%	-1416.01%	-276483.33%	-16929.86%	-4845.77%	-	-
Profit Margin	-394.91%	-2482.82%	1.27%	-230.68%	-1416.01%	-276060.00%	-17094.20%	-4977.31%	-	-
Free Cash Flow Margin	-242.06%	-1025.70%	-36.29%	-166.90%	-1246.80%	-264293.33%	-14895.36%	-4367.69%	-	-
EBITDA	-32.42	-32.8	0.55	-18.03	-30.56	-82.63	-58.79	-25.82	-17.58	-10.16
EBITDA Margin	-394.09%	-2471.89%	1.87%	-228.40%	-1406.30%	-275430.00%	-17041.45%	-4964.81%	-	-
Depreciation & Amortization	0.07	0.15	0.18	0.18	0.21	0.19	0.18	0.07	0.06	0.03
EBIT	-32.49	-32.95	0.38	-18.21	-30.77	-82.82	-58.98	-25.88	-17.64	-10.19
EBIT Margin	-394.91%	-2482.82%	1.27%	-230.68%	-1416.01%	-276060.00%	-17094.20%	-4977.31%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).